Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumour markers
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Comparison between CEA, CA 19-9 and CA 72-4 in Patients with Colon Cancer
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Tumor marker - Akesis Life - Integrative Oncology
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer - ScienceDirect
CA19.9 – Pancreatic Cancer Marker – RAAVI
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
Raised Digestive Tumour Markers in Singapore - Dr Benjamin Yip
AFP, CEA, CA 19-9 and TPA in Hepatocellular Carcinoma | Semantic Scholar
Tumor Marker Control | Fujirebio
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
CA 125, CA 15-3, CA 19-9 and CEA assay values during the three... | Download Table
